PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy. [electronic resource]
- PloS one 2015
- e0139867 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0139867 doi
Antineoplastic Agents--therapeutic use B7-H1 Antigen--antagonists & inhibitors Bone Marrow Cells--metabolism Dendritic Cells--metabolism Flow Cytometry Humans Multiple Myeloma--drug therapy Plasma Cells--metabolism